Get started
Author

Andrea Zhao

Institution: UNSW Sydney
ORCID: 0000-0001-5898-096X
Observed ORCID: 0000-0001-5898-096X
OpenAlex ID: A5116149652
Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition
2026 · Wenxin Hu (胡文欣), Honglin Chen (陈竑霖), et al. · Science Advances · 4
PK 11195 derivatives: exploring the influence of amide and heterocyclic substitution on A147T TSPO discrimination
2025 · Renee Sokias, Andrea Zhao, et al. · RSC Medicinal Chemistry · 2
PDF
Supplemental Figure 7. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 12. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 1. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 11. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 2. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 9. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 3. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 6. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 14. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplementary Table 1 from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 13. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 10. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 8. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Data from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplementary Tables 3-6 from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 4. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplementary Table 2 from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Supplemental Figure 5. from Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
2026 · Ashleigh M. Fordham, Lauren M. Brown, et al.
Works count: 20
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type